The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 16 of the 23 sources its claims cite were checked for support.
Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda
Open accessAbstract
BACKGROUND: In low-resource settings, limited laboratory capacity adds to the burden of central nervous system (CNS) infections in children and spurs overuse of antibiotics. The commercially available BioFire® FilmArray® Meningitis/Encephalitis Panel (FA-ME) with its capability to simultaneously detect 14 pathogens in cerebrospinal fluid (CSF), could potentially narrow such a diagnostic gap. METHODS: In Mbarara, Uganda, we compared clinical utility (clinical turnaround time [cTAT], microbial yield, and influence on patient outcome and antibiotic exposure) of FA-ME with bacterial culture, in children 0-12 years with suspected CNS infection. RESULTS: Of 212 enrolled children, CSF was sampled from 194. All samples underwent bacterial culture, of which 193 also underwent FA-ME analyses. FA-ME analyses prospectively influenced care for 169 of the 193 patients, and they constituted an 'Index group'. The remaining 43/212 patients constituted a 'Reference group'. Of all 194 CSF-sampled patients, 87% (168) had received antibiotics before lumbar puncture. Median cTAT for FA-ME was 4.2 h, vs. two days for culture. Bacterial yield was 12% (24/193) and 1.5% (3/194) for FA-ME and culture, respectively. FA-ME viral yield was 12% (23/193). Fatality rate was 14% in the Index group vs. 19% in the Reference group (P = 0.20). From clinician receival of FA-ME results, median antibiotic exposure was 6 days for bacteria-negative vs. 13 days for bacteria-positive patients (P = 0.03). Median hospitalization duration was 7 vs. 12 days for FA-ME negative and positive patients, respectively (P < 0.01). CONCLUSIONS: In this setting, clinical FA-ME utility was found in a higher and faster microbial yield and shortened hospitalization and antibiotic exposure of patients without CSF pathology. More epidemiologically customized pathogen panels may increase FA-ME utility locally, although its use in similar settings would require major cost reductions. TRIAL REGISTRATION: The trial was registered with clinicaltrials.gov (NCT03900091) in March 2019, and its protocol was published in November 2020.
Overview
CoChat Summary
## TL;DR
This prospective study in southwestern Uganda found that the FilmArray® meningitis/encephalitis panel (FA-ME) gave faster and higher-yield CSF microbiology than culture in children with suspected CNS infection. It also shortened antibiotic exposure and hospitalization among FA-ME-negative patients, but the authors emphasize that high cost and local epidemiology limit routine use.
## Key findings
- Among 212 enrolled children, CSF was sampled from 194; FA-ME was performed on 193 samples and culture on all 194 CSF samples.
- FA-ME microbial yield exceeded culture: bacteria were detected in 24/193 (12%) by FA-ME versus 3/194 (1.5%) by culture; FA-ME also detected viruses in 23/193 (12%) samples.
- Median clinical turnaround time was 4.2 hours for FA-ME versus 2 days for culture.
- After clinicians received FA-ME results, median antibiotic exposure was 6 days for bacteria-negative patients versus 13 days for bacteria-positive patients (P = 0.03), and median hospitalization was 7 versus 12 days for FA-ME-negative versus FA-ME-positive patients (P < 0.01).
- Fatality was 14% in the Index group versus 19% in the Reference group (P = 0.20), and overall mortality did not differ significantly by whether diagnosis was supported by FA-ME.
## Methods
- Prospective observational study nested in the PI-POC trial, conducted March 2019 to July 2020 at two hospitals in Mbarara, southwestern Uganda, among children aged 0–12 years hospitalized with suspected CNS infection.
- Compared FA-ME with bacterial culture for clinical utility outcomes: clinical turnaround time (defined as lumbar puncture to clinicians receiving results), microbial yield, patient outcome, antibiotic exposure, and hospitalization duration.
- Used descriptive statistics plus Mann-Whitney U tests for continuous variables and chi-square tests for categorical variables.
## Limitations
- The study states it did not routinely perform confirmatory testing with alternative molecular methods (e.g., GeneXpert, CrAg), so diagnostic accuracy could not be assessed.
- The study lacked a formal control group without FA-ME, which the authors say was considered unethical because empiric antibiotics before lumbar puncture already reduced culture yield.
- The unplanned Reference group was not matched to the Index group; seven Reference participants had severe clinical conditions, which the authors say could have introduced selection bias.
- Evidence made evident by the text: many children had antibiotics before lumbar puncture (168/194, 87%), which likely lowered culture yield and complicates comparison with FA-ME.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Microorganisms detectable by the FilmArray ME panel [18]](https://figures.cochat.ai/paper-figures/1e94c3bd0ab349a19c9823af455d9e0a/clinical-utility-of-the-filmarray-meningitis-encephalitis-panel-in-children-with-figure-1.jpg)




Verification
Claims the paper makes
8 Valid · 0 Not valid · 1 Not checked · 34 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Despite extensive literature on the use and performance of FA-ME, most studies focus on diagnostic accuracy, with only a few conducting prospective field evaluations to assess its clinical utility [21].”
§ Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda > Introduction
What the sources say
- Partly supportedcites [21] Radmard S, Reid S, Ciryam P, Boubour A, Ho N, Zucker J et al. Clinical utilization of the filmarray meningitis/encephalitis (ME) multiplex polymerase chain reaction (PCR) assay. Front Neurol. 2019;10(281). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says multiple studies evaluated FA-ME performance but only a few evaluated its clinical implementation, supporting the broad comparison. It does not characterize those few studies as prospective field evaluations; the Methods describe this paper’s own implementation study as retrospective. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, very few of these studies were conducted in LRS [22, 23].”
§ Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda > Introduction
What the sources say
- Partly supportedcites [22] Bridge S, Hullsiek KH, Nerima C, Evans EE, Nuwagira E, Stadelman AM, et al. Evaluation of the BioFire® FilmArray® meningitis/encephalitis panel in an adult and pediatric Ugandan population. J Med Mycol. 2021;31(3):101170. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) calls this study among the first to evaluate multiplex PCR meningitis testing in children in a resource-limited setting. The Introduction (page unavailable) says such testing is emerging in low-income countries. These passages support the idea that studies in these settings were uncommon, but the explicit rarity statement is limited to pediatric testing, not FA-ME clinical-utility studies generally. (LLM, conf=0.79)
- Supportedcites [23] Bårnes GK, Gudina EK, Berhane M, Abdissa A, Tesfaw G, Abebe G, et al. New molecular tools for meningitis diagnostics in Ethiopia - a necessary step towards improving antimicrobial prescription. BMC Infect Dis. 2018;18(1):684. source
The Abstract Methods describe a prospective FilmArray study in an Ethiopian teaching hospital with limited laboratory resources. The Methods and Discussion address clinical treatment and patient management, so this paper is an example of the low-resource-setting studies the citing sentence identifies. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another microorganism not targeted by FA-ME is Mycobacterium tuberculosis, despite it being a major cause of childhood CNS infection in tuberculosis endemic areas such as Uganda [6, 20].”
§ Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda > Discussion
What the sources say
- Partly supportedcites [6] Robertson FC, Lepard JR, Mekary RA, Davis MC, Yunusa I, Gormley WB et al. Epidemiology of central nervous system infectious diseases: a meta-analysis and systematic review with implications for neurosurgeons worldwide. J Neurosurg. 2019;130(4):1107–26. sourceExperimental — accuracy not yet measured
The Results (page unavailable) identify tuberculosis-related CNS disease and report a high incidence of tuberculous spondylodiscitis in Africa. They do not establish that Mycobacterium tuberculosis is a major cause of childhood CNS infection in Uganda or other tuberculosis-endemic areas. (LLM, conf=0.76)
- Partly supportedcites [20] Vetter P, Schibler M, Herrmann JL, Boutolleau D. Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach. Clin Microbiol Infect. 2020;26(6):706–12. sourceExperimental — accuracy not yet measured
The “Multiplex PCR panels: analytical and clinical performances” section lists the FilmArray ME targets without M. tuberculosis, and “Qualitative versus quantitative assays” says its burden is highest in low- and middle-income countries. The paper does not establish that it is a major cause of childhood CNS infection in Uganda or other tuberculosis-endemic areas (page numbers unavailable). (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, a substantial number of children who underwent LP due to suspected CNS infection showed no signs of infection in their CSF.”
§ Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda > Conclusions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From clinician receival of FA-ME results, median antibiotic exposure was 6 days for bacteria-negative vs. 13 days for bacteria-positive patients (P = 0.03).”
- Also stated in: § FA-ME influence on duration of antibiotic therapy · plain
“The difference between the two groups was statistically significant (P = 0.03).”
§ Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda > Abstract > Results
plainstates an associationn = 104 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § FA-ME influence on duration of antibiotic therapy · plain
23 more claims
Create a free account to see all 43 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 6
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“Data officers transferred the data to a digital data-base hosted by the REDCap electronic data capture tools hosted at the Karolinska Institutet; quality control was performed on the dataset [29, 30].”
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013 · cited 1×
“Data officers transferred the data to a digital data-base hosted by the REDCap electronic data capture tools hosted at the Karolinska Institutet; quality control was performed on the dataset [29, 30].”
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Laboratory medicine in Africa: a barrier to effective health care
Petti, C. A., Polage, C. R., Quinn, T. C., Ronald, A. R., & Sande, M. A. (2006) · Clinical Infectious Diseases · doi:10.1086/499363 · Cited by 749 · cited 1×
“Discerning CNS aetiology thus becomes a challenging task that impedes appropriate and timely treatment of patients, allows for over-treatment with empirical broad-spectrum drugs, and adds to the burden of disease and the spread of antimicrobial resistance [2, 8–11].”
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609 · cited 2×
“1) in minimal CSF volumes, offering reduced turnaround time and high diagnostic accuracy [1, 3, 17–19].”
Requirements for high impact diagnostics in the developing world
Urdea, M., Penny, L. A., Olmsted, S. S., Giovanni, M. Y., Kaspar, P., Shepherd, A., Wilson, P., Dahl, C. A., Buchsbaum, S., Moeller, G., et al. (2006) · Nature · doi:10.1038/nature05448 · Cited by 594
Bacterial meningitis in children
Sáez-Llorens, X., & McCracken, G. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13693-8 · Cited by 533
Garges, H. P., Moody, M. A., Cotten, C. M., Smith, P. B., Tiffany, K. F., Lenfestey, R., Li, J. S., Fowler, V. G., & Benjamin, D. K. (2006) · Pediatrics · doi:10.1542/peds.2005-1132 · Cited by 351 · cited 1×
“Even though the absence of pleocytosis in children (and especially neonates) with confirmed CNS infection has been reported [16, 39, 40], our findings could also represent sample contamination, or false FA-ME results.”
Tansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263 · cited 3×
“While its user-friendliness and multiplexity have the potential to narrow the diagnostic gap of CNS infection diagnostics in resource-limited settings, the current cost and logistical needs of FA-ME might deter its implementation [14, 18, 20].”
Nauclér, P., Huttner, A., van Werkhoven, C. H., Singer, M., Tattevin, P., Einav, S., & Tängdén, T. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.032 · Cited by 131 · cited 1×
“Prompt and effective diagnosis and treat-ment of CNS infections, particularly bacterial meningitis, are crucial for favourable outcomes due to their high morbidity and mortality [2–5].”
Research works printed but not linked: 2
- Institute for Health Metrics and Evaluation: Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) reference life table. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME); 2021. [Available from: ghdx.healthdata.org/.
- First of 3 diagnostic tests for SARS-CoV-. 2 coronavirus available from bioMérieux [press release]. https://www.biomerieux.com/en/novel-coronavirus-covid-19, 11 March.
Cited by
Subedi, S., Harris, P. N. A., Hall, L., & Paterson, D. L. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.06.013 · Cited by 14
Gres, E., Brigadoi, G., Zamperetti, E., Dramowski, A., Dahourou, D. L., Mavoko, H. M., Matuvanga, T. Z., Hamers, R. L., Leroy, V., Donà, D., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103667 · Cited by 11
Wu, C., Sun, X., Zhang, W., Yang, Y., Niu, P., Chen, J., Zhang, X., Lu, R., Wang, W., Chen, Z., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12204-7 · Cited by 2
“Besides, several multiplex pathogen detection kits have been applied for diagnosing central nervous system infection pathogens, such as the FilmArray® Meningitis/Encephalitis panel [23].”
Chen, J., Wang, Y.-X., Zhou, Y., et al. (2026) · European Journal of Pediatrics · doi:10.1007/s00431-026-07168-y · Cited by 1
Aubry, A., Brochot, É., Demey, B., Louchet-Ducoroy, M., Pannier, C., Segard, C., François, C., & Castelain, S. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108977
Metadata
- Authors
- Rasti, R., Kumbakumba, E., Nanjebe, D., Mlotshwa, P., Nassejje, M., Mzee, J., Businge, S., Akankwasa, G., Nyehangane, D., Gantelius, J., Boum, Y., Mårtensson, A., Mwanga-Amumpaire, J., Alfvén, T., & Gaudenzi, G.
- Affiliations
- Karolinska Institutet (SE)
- Mbarara University of Science and Technology (UG)
- Epicentre Uganda (UG)
- Holy Innocents Children's Hospital (UG)
- Science for Life Laboratory (SE)
- Uppsala University (SE)
- Corresponding author
- Rasti, Reza
- ORCID
- Venue
- BMC Infectious Diseases
- Published
- 2025-03-22
- Volume
- 25
- Issue
- 1
- Pages
- 396-396
- ISSN
- 1471-2334 (ISSN-L)
- PMC
- PMC11930002
- OpenAlex
- W4408729760
- Cited by
- 8
- References
- 35
- Citations by year
- 2026: 5 · 2025: 3
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Karolinska Institute
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- FilmArray Meningitis/Encephalitis panel, central nervous system infection, pediatric meningitis, encephalitis, cerebrospinal fluid, molecular diagnosis, bacterial culture comparison, antibiotic exposure, resource-limited settings, southwestern Uganda, length of hospital stay, fatality rate, virus detection, antimicrobial stewardship, point-of-care testing
- MeSH terms
- Anti-Bacterial Agents, Bacteria, Central Nervous System Infections, Child, Child, Preschool, Encephalitis, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Prospective Studies, Uganda, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda. https://app.cochat.ai/papers/10.1186/s12879-025-10732-w
- The paper
- Rasti, R., Kumbakumba, E., Nanjebe, D., Mlotshwa, P., Nassejje, M., Mzee, J., Businge, S., Akankwasa, G., Nyehangane, D., Gantelius, J., Boum, Y., Mårtensson, A., Mwanga-Amumpaire, J., Alfvén, T., & Gaudenzi, G. (2025). Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in Southwestern Uganda. BMC Infectious Diseases. https://doi.org/10.1186/s12879-025-10732-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.